Neuroendocrine markers expression in pancreatic serous cystadenoma.
Kanehira
Kazunori
K
Department of Pathology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Khoury
Thaer
T
D000368:Aged; D000951:Antigens, Neoplasm / Q000032:analysis* / Q000235:genetics; D001706:Biopsy; D019002:CD56 Antigen / Q000032:analysis / Q000235:genetics; D053379:Chromogranin A / Q000032:analysis* / Q000235:genetics; D018293:Cystadenoma, Serous / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D003951:Diagnostic Errors; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007515:Islets of Langerhans / Q000473:pathology; D008297:Male; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D010179:Pancreas / Q000378:metabolism / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D012189:Retrospective Studies; D016708:Synaptophysin / Q000032:analysis / Q000235:genetics
D000951:Antigens, Neoplasm; D019002:CD56 Antigen; D053379:Chromogranin A; D016708:Synaptophysin